Imaging for Multiple Myeloma
Imaging for Multiple Myeloma Professor of Oncology and Internal Medicine, Jens Hillengass, MD, discusses imaging for multiple myeloma. Learn more: www.roswellpark.org/cancer/multiple-myeloma
Read MoreImaging for Multiple Myeloma Professor of Oncology and Internal Medicine, Jens Hillengass, MD, discusses imaging for multiple myeloma. Learn more: www.roswellpark.org/cancer/multiple-myeloma
Read MoreExample: Through my research, I discovered old-fashioned practices for abortions and birth control and other home remedies during and after slavery. The deeper level of meaning was that life was almost so unbearable for Black women at that point in history that women would rather abort using primitive methods and risk her life than bring […]
Read MoreVitamin D: Studies link nutrient with reduced risk of advanced cancer, improved COVID recovery Vitamin D: Studies link nutrient with reduced risk of advanced cancer, improved COVID recovery& |  Photo Credit: iStock Images Key Highlights Vitamin D deficiency has been linked with an increased risk of COVID-19, and severe symptoms due to the disease A recent […]
Read MoreHitachi launches “treatment support for cancer drug therapy” using AI interviews & tablet robots The Cancer Institute Ariake Hospital and Hitachi will carry out this research from the end of November 2020 to the end of March 2022 as part of measures to reduce the workload of medical staff. The Japanese Foundation for Cancer Research […]
Read MoreWhat should you do if you are diagnosed with pancreatic cancer? Know steps for diagnosis … What should you do if you are diagnosed with pancreatic cancer? Know steps for diagnosis, prevention& |  Photo Credit: iStock Images Key Highlights Pancreatic cancer is a rare cancer that affects a few people around the world The cancer can […]
Read MoreFire Extinguisher Market: Impact and Recovery Report | Evolving Opportunities and New Market … BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that the China National Medical Products Administration (NMPA) has approved XGEVA (denosumab) for the prevention of skeletal-related events (SREs) in patients […]
Read More